Menu

UroGen Pharma Ltd. URGN

Full chart Compare
Set alert

Price alert · URGN

All alert types
26.10 USD +0.78 (+3.08%)

At closeNov 12, 2026, 4:07 AM EST

25.88 -0.22 -0.84%

Pre-market · Nov 12, 4:07 AM ET

25.40 Day range 26.24
16.50 52-week range 50.81
YTD
+11.44%
1 year
+3.82%

Revenue & Expenses

Revenue → Gross Profit: $97.34MGross Profit → Expenses: $97.34MRevenue → Cost of Revenue: $12.45MExpenses → Selling, General & Admin: $155.10MExpenses → Research & Development: $67.11MExpenses → Other Expenses: $28.55MExpenses → Income Tax: $78.00KNet Loss → Expenses: $153.49MGross Profit$97.34MNet Loss$153.49MCost of Revenue$12.45MExpenses$250.84MSelling, General & Admin$155.10MResearch & Development$67.11MOther Expenses$28.55MIncome Tax$78.00KRevenue$109.79M

Latest period ending Dec 31, 2025 · select a line to chart its full history

Annual income statement

URGN annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
109.79M90.40M82.71M64.36M48.04M
109.79M90.40M82.71M64.36M48.04M
12.45M8.88M9.36M7.65M5.16M
97.34M81.52M73.35M56.70M42.88M
222.20M178.30M138.89M135.74M135.18M
67.11M57.15M45.61M52.91M47.64M
155.10M121.15M93.27M82.84M87.53M
-124.86M-96.78M-65.54M-79.04M-92.29M
15.35M12.52M14.71M8.44M0
78.00K2.83M3.92M1.75M1.45M
-153.49M-126.87M-102.24M-109.78M-110.82M
-153.49M-126.87M-102.24M-109.78M-110.82M
-153.49M-126.87M-102.24M-109.78M-110.82M
-153.49M-126.87M-102.24M-109.78M-110.82M
-3.19-2.96-3.55-4.81-4.96
-3.19-2.96-3.55-4.81-4.96
-3.19-2.96-3.55-4.81-4.96
-138.07M-111.52M-83.61M-99.59M-109.37M
-138.07M-111.52M-83.61M-99.59M-109.37M
48.12M42.88M28.83M22.81M22.35M
48.12M42.88M28.83M22.81M22.35M